UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 863

Sortiert nach

Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants

The International journal of drug policy, 2019-12, Vol.74, p.246-254

2019

Volltextzugriff (PDF)

Pilot phase of an internet-based RCT of HIVST targeting MSM and transgender people in England and Wales: advertising strategies and acceptability of the intervention

BMC infectious diseases, 2019-08, Vol.19 (1), p.699-13, Article 699

2019

Volltextzugriff (PDF)

Protocol, rationale and design of SELPHI: a randomised controlled trial assessing whether offering free HIV self-testing kits via the internet increases the rate of HIV diagnosis

BMC infectious diseases, 2018-10, Vol.18 (1), p.531-10, Article 531

2018

Volltextzugriff (PDF)

The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection

Health technology assessment (Winchester, England), 2016-03, Vol.20 (21), p.1-158

2016

Volltextzugriff (PDF)

Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir

The Journal of infectious diseases, 2010-01, Vol.201 (1), p.106-113

2010

Volltextzugriff (PDF)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

PloS one, 2014-03, Vol.9 (3), p.e90772

2014

Volltextzugriff (PDF)

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2012-07, Vol.308 (4), p.353

2012

Volltextzugriff (PDF)

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions

AIDS (London), 2014-08, Vol.28 (13), p.1967-1975

2014

Volltextzugriff (PDF)

Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy

AIDS (London), 2016-11, Vol.30 (17), p.2617-2624

2016

Volltextzugriff (PDF)

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom

The Journal of infectious diseases, 2016-11, Vol.214 (9), p.1302-1308

2016

Volltextzugriff (PDF)

Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial

Sexually transmitted infections, 2019-09, Vol.95 (6), p.449

2019

Volltextzugriff (PDF)

Exploring Mechanisms of Action: Using a Testing Typology to Understand Intervention Performance in an HIV Self-Testing RCT in England and Wales

International journal of environmental research and public health, 2020-01, Vol.17 (2), p.466

2020

Volltextzugriff (PDF)

Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial

PharmacoEconomics, 2016-08, Vol.34 (8), p.795-804

2016

Volltextzugriff (PDF)

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

AIDS (London), 2013-09, Vol.27 (14), p.2245-2253

2013

Volltextzugriff (PDF)

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy

AIDS (London), 2002-05, Vol.16 (8), p.1139-1146

2002

Volltextzugriff (PDF)

Adipogenic gene variants in patients with HIV-associated lipodystrophy

Pharmacogenetics and genomics, 2011-02, Vol.21 (2), p.76-83

2011

Volltextzugriff (PDF)

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Antiviral therapy, 2012-01, Vol.17 (7), p.1363-1373

2012

Volltextzugriff (PDF)

Does Discordancy Between the CD4 Count and CD4 Percentage in HIV-Positive Individuals Influence Outcomes on Highly Active Antiretroviral Therapy?

The Journal of infectious diseases, 2012-02, Vol.205 (4), p.540-547

2012

Volltextzugriff (PDF)

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom

Antiviral therapy, 2010-01, Vol.15 (7), p.985-991

2010

Volltextzugriff (PDF)

Persistence of HIV-1 Transmitted Drug Resistance Mutations

The Journal of infectious diseases, 2013-11, Vol.208 (9), p.1459-1463

2013

Volltextzugriff (PDF)

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis

Trials, 2016-03, Vol.17 (1), p.163, Article 163

2016

Volltextzugriff (PDF)

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial

The lancet HIV, 2015-10, Vol.2 (10), p.e417-e426

2015

Volltextzugriff (PDF)

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs

Journal of antimicrobial chemotherapy, 2017-07, Vol.72 (7), p.2075-2082

2017

Volltextzugriff (PDF)

The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data

BMC infectious diseases, 2017-02, Vol.17 (1), p.160-160, Article 160

2017

Volltextzugriff (PDF)

1 – 25 von 863

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(816)
Mit Volltextzugriff
(709)

Publikationsform

Artikel
(863)

Sprache

Englisch
(863)
Japanisch
(119)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(34)
Transplantation
(21)
Hiv Medicine
(16)
The Journal Of Infectious Diseases
(16)
The journal Of Infectious Diseases
(16)
Plos One
(13)
The American Journal Of Sports Medicine
(13)
The Lancet
(13)
The New England Journal Of Medicine
(13)
American Journal Of Ophthalmology
(11)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants

Pilot phase of an internet-based RCT of HIVST targeting MSM and transgender people in England and Wales: advertising strategies and acceptability of the intervention

Protocol, rationale and design of SELPHI: a randomised controlled trial assessing whether offering free HIV self-testing kits via the internet increases the rate of HIV diagnosis

The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection

Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions

Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom

Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial

Exploring Mechanisms of Action: Using a Testing Typology to Understand Intervention Performance in an HIV Self-Testing RCT in England and Wales

Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy

Adipogenic gene variants in patients with HIV-associated lipodystrophy

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Does Discordancy Between the CD4 Count and CD4 Percentage in HIV-Positive Individuals Influence Outcomes on Highly Active Antiretroviral Therapy?

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom

Persistence of HIV-1 Transmitted Drug Resistance Mutations

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs

The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data

Aktive Filter

Suchergebnisse filtern